We use essential cookies (authentication, your saved goals/stack) by default. With your permission we’ll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Head-to-head evidence comparison — which supplement is right for you?
Berberine vs Green Tea Extract: Green Tea Extract has the stronger overall evidence (7.5 vs 7.5/10); they're alternatives for manage blood sugar — the best pick depends on your goals. Take the 60-second quiz for a pick tailored to your goals.
Green Tea Extract wins 1 of 3 categories. Both are solid choices — the best pick depends on your specific goals.
Verdict
Likely helps
8 of 8 studies with measurable effects showed benefit.
Top outcomes
Verdict
Likely helps
5 of 7 studies with measurable effects showed benefit.
Top outcomes
Shared outcomes (1)
Outcomes where both Berberine and Green Tea Extract have evidence — compare verdict strength side-by-side.
500mg 2-3x daily (1000-1500mg total)
With meals, Split into 2-3 doses
Berberine HCl capsules
250-338mg EGCG a day with food (about 500-675mg of an extract standardised to 50% EGCG). 338 mg is a review-derived precaution (PMID 29580974), not an upper limit and not proof of safety
With meals, Morning or pre-exercise
Standardized extract (45-50% EGCG)
and 3 more not shown
and 2 more not shown
4-12 weeks
8-12 weeks
First 2 weeks
If on diabetes medications
Acute and 4-8 weeks
Acute
30-60 minutes
Clinical Efficacy of Curcumin, Resveratrol, Silymarin, and Berberine on Cardio-Metabolic Risk Factors Among Patients With Type 2 Diabetes Mellitus: A Systemic Review and Bayesian Network Meta-Analysis
Phytotherapy research : PTR (2025) · Meta analysis · n=1337
For HbA1c, silymarin was more effective than resveratrol (MD -2.08, 95%Cl -3.50 to -0.72) (P < 0.05).
Effects of berberine and barberry on selected inflammatory biomarkers in adults: A systematic review and dose-response meta-analysis of randomized clinical trials
Phytotherapy research : PTR (2023) · Meta analysis · n=1600
In addition, the non-linear analysis showed a significant lowering effect of berberine/barberry on IL-6 and TNF-α levels in doses <1000 mg/day and less than 5 weeks of intervention.
Berberine Ursodeoxycholate for the Treatment of Type 2 Diabetes: A Randomized Clinical Trial
JAMA network open (2025) · Rct · n=113
The study included 113 patients with T2D (mean [SD] age, 54.3 [10.6] years; 72 male [63.7%]) who were randomized.
Green tea (Camellia sinensis) for the prevention of cancer
The Cochrane database of systematic reviews (2020) · Meta analysis · n=1795
For incident prostate cancer, the summary risk ratio (RR) in the green tea-supplemented participants was 0.50 (95% confidence interval (CI) 0.18 to 1.36), based on three studies and involving 201 participants (low-certainty evidence).
Impact of flavan-3-ols on blood pressure and endothelial function in diverse populations: a systematic review and meta-analysis of randomized controlled trials
European journal of preventive cardiology (2025) · Meta analysis · n=5205
Flavan-3-ol interventions included epicatechin, epigallocatechin-gallate, cocoa products, tea, grape extract, and apples delivering 586 mg (95% CI 510, 662) total flavan-3-ols.
The effects of green tea extract supplementation on body composition, obesity-related hormones and oxidative stress markers: a grade-assessed systematic review and dose-response meta-analysis of randomised controlled trials
The British journal of nutrition (2024) · Meta analysis · n=3802
Pooled effect sizes indicated that BM, BFP, BMI and MDA significantly reduced following GTE supplementation.
The 1,000 mg point is a placebo-controlled trial of berberine 1.0 g daily for 3 months in 116 people with type 2 diabetes, where HbA1c fell from 7.5% to 6.6% and fasting glucose fell more than on placebo (PMID 18397984). The 1,500 mg point is two trials of 500 mg three times daily: one in 36 people with new type 2 diabetes where glucose fell with no significant difference from metformin in this small pilot, with transient stomach side effects in 34.5% (PMID 18442638), and a placebo-controlled pilot in 34 people with prediabetes where HbA1c fell from 6.40% to 5.43% (PMID 37679692). No trial compared doses, so the curve is flat between them and no optimal dose is set. Lower doses were not tested for glucose in any cited trial.
Both points come from a systematic review of 17 randomised trials in 1,356 healthy adults (PMID 27324590), which found that 107 to 856 mg of EGCG a day for 4 to 14 weeks lowered LDL cholesterol by about 9.3 mg/dl, at any dose in that range. The effect depended slightly on baseline lipids, not on dose, so the curve is flat. A 12-week trial at 856.8 mg a day in 102 women with central obesity saw a non-significant downward trend in LDL (PMID 26093535). No optimum was identified, and the 856 mg point is not a safety ceiling: a safety review derived 338 mg EGCG a day as the safe intake for solid supplement doses (PMID 29580974).
AI-estimated from published studies. Interpret as directional guidance.
Green Tea Extract has a higher evidence score (7.5/10 vs 7.5/10) and wins in 1 of 3 categories.
For manage blood sugar, Berberine has a higher relevance score (95 vs 50).
No documented interaction was found in the data searched. This does not establish that this exact combination is safe.
The honest tier list — proven staples vs situational vs mostly marketing. The hub the other guides feed into.
Which supplements clash with blood thinners, thyroid meds, antibiotics & more — and what to do.
What genuinely lowers LDL/triglycerides — and why "red yeast rice" is a statin in disguise.
Berberine, inositol, magnesium vs the cinnamon/chromium hype — and the med-interaction warning.
The right pick depends on your goals. Answer a few quick questions for a personalised recommendation — or dig into the full evidence on each.